Formulation expertise can smooth the transition of a prospective therapy from medicinal chemistry to drug dosage form.
Stephen Tindal
Advertisement
Stephen Tindal is director, Formulation and Site R&D Lead at Catalent Pharma Solutions.
Articles by Stephen Tindal
Pharmaceutical Technology Europe
Stephen Tindal from Catalent Pharma Solutions speaks with Pharmaceutical Technology Europe about advances in softgel technologies.
Advertisement
Latest Updated Articles
Opportunities with SoftgelsAugust 1st 2014
Bridging the Gap from Molecule to DrugApril 2nd 2018
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5